Menu Search
Equities

AVITA Medical Inc

51KB:BER

AVITA Medical Inc

Actions
  • Price (EUR)2.14
  • Today's Change-0.08 / -3.60%
  • Shares traded264.00
  • 1 Year change+9.74%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year AVITA Medical Inc had net income fall 112.85% from a loss of 16.52m to a larger loss of 35.16m despite a 543.96% increase in revenues from 1.27m to 8.16m.
Gross margin78.72%
Net profit margin-249.98%
Operating margin-251.09%
Return on assets-47.05%
Return on equity-52.30%
Return on investment-51.04%
More ▼

Cash flow in AUDView more

In 2019, AVITA Medical Inc increased its cash reserves by 95.50%, or 14.16m. Cash Flow from Financing totalled 41.30m or 505.96% of revenues. In addition the company used 27.49m for operations while cash used for investing totalled 1.79m.
Cash flow per share-0.0146
Price/Cash flow per share--
Book value per share0.0117
Tangible book value per share0.0117
More ▼

Balance sheet in AUDView more

AVITA Medical Inc has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 28.70m.
Current ratio15.37
Quick ratio15.22
Total debt/total equity0.031
Total debt/total capital0.0301
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.